Hyloris Pharmaceuticals SA (EBR:HYL)
Belgium
· Delayed Price · Currency is EUR 5.24
-0.10 (-1.87%)
Apr 29, 2026, 12:02 PM CET
Hyloris Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | -6.33 | -6.34 | -15.38 | -11.91 | -11.58 | Upgrade
|
| Depreciation & Amortization | 0.92 | 0.45 | 0.38 | 0.15 | 0.11 | Upgrade
|
| Other Amortization | - | 0.19 | -0.12 | 0.08 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.02 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.09 | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.97 | 0.97 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.07 | 0.08 | 0.15 | 0.13 | 0.19 | Upgrade
|
| Stock-Based Compensation | 0.67 | -0.58 | 0.54 | 0.56 | 0.58 | Upgrade
|
| Other Operating Activities | -0.65 | -0.34 | -0.7 | -0.06 | 0.2 | Upgrade
|
| Change in Accounts Receivable | -0.29 | -1.88 | 0.03 | -0.92 | -2.07 | Upgrade
|
| Change in Inventory | -0.05 | - | - | - | - | Upgrade
|
| Change in Accounts Payable | -0.42 | 0.14 | 1.05 | -0.47 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.07 | 0.4 | 1.16 | -0.59 | 1.29 | Upgrade
|
| Operating Cash Flow | -6.99 | -6.9 | -12.81 | -13.02 | -11.25 | Upgrade
|
| Capital Expenditures | -0 | -0.03 | -0.3 | -0.1 | -0.11 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.63 | -0.27 | -0.45 | -0.64 | -0.74 | Upgrade
|
| Investment in Securities | -1.9 | - | 10 | -10.5 | -2.23 | Upgrade
|
| Other Investing Activities | 0.4 | 0.56 | 0.64 | 0.52 | -0 | Upgrade
|
| Investing Cash Flow | -2.13 | 0.26 | 9.89 | -11.37 | -3.08 | Upgrade
|
| Long-Term Debt Issued | - | 0.14 | 0.05 | - | - | Upgrade
|
| Total Debt Issued | - | 0.14 | 0.05 | - | - | Upgrade
|
| Long-Term Debt Repaid | -0.34 | -0.31 | -0.17 | -7.46 | -0.06 | Upgrade
|
| Net Debt Issued (Repaid) | -0.34 | -0.17 | -0.12 | -7.46 | -0.06 | Upgrade
|
| Issuance of Common Stock | - | - | - | 17.17 | - | Upgrade
|
| Other Financing Activities | -0.09 | - | -0.01 | -1.88 | - | Upgrade
|
| Financing Cash Flow | -0.43 | -0.17 | -0.13 | 7.84 | -0.06 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.27 | - | - | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | -0 | - | - | Upgrade
|
| Net Cash Flow | -9.82 | -6.81 | -3.05 | -16.56 | -14.39 | Upgrade
|
| Free Cash Flow | -7 | -6.93 | -13.11 | -13.12 | -11.36 | Upgrade
|
| Free Cash Flow Margin | -79.23% | -71.03% | -348.66% | -549.69% | -366.83% | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.25 | -0.47 | -0.48 | -0.44 | Upgrade
|
| Cash Interest Paid | 0.09 | - | 0.01 | 1.88 | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.35 | - | Upgrade
|
| Levered Free Cash Flow | -6.53 | -5.1 | -7.53 | -10.4 | -3.54 | Upgrade
|
| Unlevered Free Cash Flow | -6.06 | -5.05 | -7.5 | -10.27 | -3.2 | Upgrade
|
| Change in Working Capital | -0.69 | -1.34 | 2.23 | -1.98 | -0.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.